Feeds:
Posts
Comments

Archive for July, 2012

When I say the word leader, quite understandably most associate it with the ‘one-in-charge’, the top person. Furthermore, since leader is synonymous with the one-in-charge, then leadership must be the actions of the one-in-change. That is when the term leadership is the focus—be it in academic journals or the popular press—its use is most often referring to people in positions of authority such as top executives or c-level managers in organizations or officials of rank in government.  We could just as well talk about top management since the terms connote the same thing.  Even so, everyone would prefer to be a leader than a manager—it just sounds better. (more…)

Advertisements

Read Full Post »

The Justice Department’s $3 billion judgment against GlaxoSmithKline for criminal actions in their marketing of prescription drugs is a minor penalty to pay relative to the tens of billions they made in the process.  Chock it up to the cost of doing business!  What did GlaxoSmithKline do?  The business of GlaxoSmithKline involved the promotion of drugs for unapproved patient populations and for unapproved purposes and lobbying doctors to prescribe their products by offering trips, tips and other perks in return. Seemingly they don’t believe in markets.  They don’t believe markets will be effective and efficient in satisfying their needs, so they interfere with it. Clearly, there is no trust in markets here!  (more…)

Read Full Post »

Is the free market the best means to efficiency and effectiveness?  Let’s critically think this through. (more…)

Read Full Post »